Active Pharmaceutical Ingredient (API) Prequalified
M
Ritonavir manufactured by Qidong Dongyue Pharmaceutical Co., Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
42nd Invitation to manufacturers of Active Pharmaceutical Ingredients (API) to submit an Expression of Interest (EOI) for API evaluation to the WHO Prequalification Unit (PQT)
M
The following APIs were added:
1st Invitation to manufacturers of medicinal products for treatment of childhood cancer, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
M
The first Invitation to Manufacturers of Medicinal Products for the Treatment of Childhood Cancer to submit applications for evaluation under the WHO Prequalification Programme has been issued foll
1st Invitation to Manufacturers of Therapeutics for Sickle Cell Disease to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit (PQT)
M
The 1st Invitation for the submission of medicinal products for the treatment of Sickle Cell Disease for product evaluation by prequalification has been issued, based on a reques
WHO's Public Assessment Reports (WHOPAR) Update
ID
IVD
Between 20 June and 21 July 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequ
Chiesi Caffeine citrate solution for infusion and oral solution prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New addition to WHO's list of prequalified IVDs: Determine™ Syphilis Advanced
IVD